Cite
MLA Citation
Karl Heinz Weiss et al.. “O01 Efficacy and safety of ALXN1840 versus standard of care in Wilson disease: primary results from an ongoing phase 3, randomized, controlled, rater-blinded trial.” Gut, vol. 71, n.d., p. A1. http://access.bl.uk/ark:/81055/vdc_100167535940.0x000015